CCIA
TECH icon

Cherry Creek Investment Advisors’s Bio-Techne TECH Stock Holding History

Cherry Creek Investment Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,995
Closed -$231K – 107
2023
Q4 		$231K Sell
2,995
-77
-3% -$5.07K 0.14% 91
2023
Q3 		$209K Sell
3,072
-74
-2% -$5.85K 0.14% 84
2023
Q2 		$257K Buy
3,146
+2
+0.1% +$161 0.17% 75
2023
Q1 		$233K Buy
3,144
+2
+0.1% +$154 0.17% 77
2022
Q4 		$260K Sell
3,142
-2
-0.1% -$159 0.2% 70
2022
Q3 		$223K Buy
3,144
+4
+0.1% +$346 0.18% 80
2022
Q2 		$272K Hold
3,140
– – 0.22% 70
2022
Q1 		$340K Buy
+3,140
New +$324K 0.22% 73

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Cherry Creek Investment Advisors's TECH Position: Q1 2024 in Review

Cherry Creek Investment Advisors sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 2,995 shares — an estimated $231K sold.

Cherry Creek Investment Advisors first reported a position in TECH in Q1 2022 and held it in 8 quarters. The position peaked at $340K in Q1 2022. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

  • Cherry Creek Investment Advisors reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
  • Cherry Creek Investment Advisors sold 2,995 Bio-Techne shares in Q1 2024, an estimated $231K.
  • Cherry Creek Investment Advisors first reported a position in Bio-Techne in Q1 2022 and held it in 8 quarters.
  • Cherry Creek Investment Advisors's Bio-Techne position peaked at $340K in Q1 2022.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Cherry Creek Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.